GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (BOM:543654) » Definitions » EBITDA

Global Health (BOM:543654) EBITDA : ₹8,737 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Health EBITDA?

Global Health's EBITDA for the three months ended in Mar. 2024 was ₹2,068 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8,737 Mil.

During the past 12 months, the average EBITDA Growth Rate of Global Health was 29.00% per year. During the past 3 years, the average EBITDA Growth Rate was 57.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 5 years, the highest 3-Year average EBITDA Growth Rate of Global Health was 57.70% per year. The lowest was 43.30% per year. And the median was 50.50% per year.

Global Health's EBITDA per Share for the three months ended in Mar. 2024 was ₹7.69. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹32.52.

During the past 12 months, the average EBITDA per Share Growth Rate of Global Health was 24.60% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 54.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 5 years, the highest 3-Year average EBITDA per Share Growth Rate of Global Health was 54.40% per year. The lowest was 41.90% per year. And the median was 48.15% per year.


Global Health EBITDA Historical Data

The historical data trend for Global Health's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health EBITDA Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA
2,298.92 2,227.79 4,897.56 6,771.24 8,737.40

Global Health Quarterly Data
Mar20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,915.09 1,993.41 2,336.02 2,340.26 2,067.70

Competitive Comparison of Global Health's EBITDA

For the Medical Care Facilities subindustry, Global Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Global Health's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Global Health's EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Global Health's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2024, Global Health's EBITDA was ₹8,737 Mil.

Global Health's EBITDA for the quarter that ended in Mar. 2024 is calculated as

Global Health's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2024, Global Health's EBITDA was ₹2,068 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8,737 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Global Health  (BOM:543654) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Global Health EBITDA Related Terms

Thank you for viewing the detailed overview of Global Health's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health (BOM:543654) Business Description

Traded in Other Exchanges
Address
E - 18, Medanta - The Medicity, Defence Colony, New Delhi, IND, 110024
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health (BOM:543654) Headlines

No Headlines